
70.49 Delayed Data As of Apr 09 | ![]() Today’s Change | 12.19 Today|||52-Week Range 92.00 | +29.58% Year-to-Date |
Intellia Therapeutics Inc (NTLA) EVP, General Counsel Jose E Rivera Sold $4.2 million of Shares Apr 05 / GuruFocus News - Paid Partner Content | Here's the Holy Grail of Gene Editing Apr 02 / MotleyFool.com - Paid Partner Content |
Previous close | 73.08 |
Today’s open | 73.02 |
Day’s range | 70.20 - 73.65 |
Volume | 33,260 |
Average volume (3 months) | 1,705,352 |
Market cap | $5.4B |
Earnings growth (last year) | -13.81% |
Earnings growth (this year) | -17.77% |
Earnings growth (next 5 years) | -- |
Revenue growth (last year) | +34.55% |
P/E ratio | NM |
Price/Sales | 52.52 |
Price/Book | 10.05 |
Next reporting date | May 4, 2021 |
EPS forecast (this quarter) | -$0.67 |
Annual revenue (last year) | $58.0M |
Annual profit (last year) | -$134.2M |
Net profit margin | -231.46% |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |